GELATIN SPONGE MARKET ANALYSIS

Gelatin Sponge Market, By Origin (Porcine, Bovine), By Application (Minimally Invasive Surgery, General Surgery, Neuro Surgery, Cardiovascular Surgery, Orthopedic Surgery, Others (ENT, Surgery, etc.)), By End User (Hospitals, Specialty Clinics, Others (Ambulatory Surgical Centers, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Oct 2023
Code : CMI4260
Pages :170
Formats :
Excel and PDF
Industry : Medical Devices

Leading Companies

Global Gelatin Sponge Market : Key Developments

In September 2020, Merit Medical Systems, a medical device company, announced that they had launched Torpedo gelatin foam, indicated for use in the embolization of hypervascular tumors. Torpedo provides physicians with preshaped gelatin foam loaded into a cartridge with an optional blunt stylet, removing the need for manual foam shaping and providing fast and easy attachment to the catheter for delivery.

Global Gelatin Sponge Market - Key Players

Major players operating in the global gelatin sponge market include Pfizer Inc., B. Braun SE, GELITA MEDICAL, CuraMedical B.V., Aegis Lifesciences, Angellifescience, EON Meditech, GOODWILL LIFESCIENCES PVT. LTD, Mil Laboratories Pvt. Ltd., EUCARE PHARMACEUTICALS (P) LTD., Medzeel Lifescience, Healthium Medtech Limited, Aegis Lifesciences, Omnia Health, and Advin Health Care.

Companies covered: Pfizer Inc., B. Braun SE, GELITA MEDICAL, CuraMedical B.V., Aegis Lifesciences, Angellifescience, EON Meditech, GOODWILL LIFESCIENCES PVT. LTD, Mil Laboratories Pvt. Ltd., EUCARE PHARMACEUTICALS (P) LTD., Medzeel Lifescience, Healthium Medtech Limited, Aegis Lifesciences, Omnia Health, and Advin Health Care.